167 related articles for article (PubMed ID: 20036471)
21. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
22. Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats.
Rimoldi G; Christoffel J; Wuttke W
Menopause; 2006; 13(4):669-77. PubMed ID: 16837889
[TBL] [Abstract][Full Text] [Related]
23. In vivo characterization of progestins with reduced non-genomic activity in vitro.
Otto C; Rohde-Schulz B; Schwarz G; Fuchs I; Klewer M; Altmann H; Fritzemeier KH
Ernst Schering Found Symp Proc; 2007; (1):151-70. PubMed ID: 18540572
[TBL] [Abstract][Full Text] [Related]
24. Morphometric evaluation of effects of two sex steroids on mammary gland of female rats.
Pompei LM; Carvalho FM; Ortiz SC; Motta MC; Cruz RJ; Melo NR
Maturitas; 2005 Aug; 51(4):370-9. PubMed ID: 16039410
[TBL] [Abstract][Full Text] [Related]
25. Effects of genistein on the mammary gland proliferation of adult ovariectomised Wistar rats.
Hertrampf T; Schmidt S; Seibel J; Laudenbach-Leschowsky U; Degen GH; Diel P
Planta Med; 2006 Mar; 72(4):304-10. PubMed ID: 16557470
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice.
Skarda J
Physiol Res; 2002; 51(4):407-12. PubMed ID: 12449440
[TBL] [Abstract][Full Text] [Related]
27. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
[TBL] [Abstract][Full Text] [Related]
28. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
29. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Lee O; Choi MR; Christov K; Ivancic D; Khan SA
Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
[TBL] [Abstract][Full Text] [Related]
30. Hormonal regulation of uterine epithelial cell proliferation. I. Effects of estradiol or progesterone administered separately.
Kiss R; Lenglet G; Pasteels JL; Danguy A
In Vivo; 1987; 1(5):281-9. PubMed ID: 2979795
[TBL] [Abstract][Full Text] [Related]
31. Mouse bioassay to assess oestrogenic and anti-oestrogenic compounds: hydroxytamoxifen, diethylstilbestrol and genistein.
Köhlerová E; Skarda J
J Vet Med A Physiol Pathol Clin Med; 2004 Jun; 51(5):209-17. PubMed ID: 15315699
[TBL] [Abstract][Full Text] [Related]
32. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model.
Raafat AM; Li S; Bennett JM; Hofseth LJ; Haslam SZ
J Cell Physiol; 2001 Apr; 187(1):81-9. PubMed ID: 11241352
[TBL] [Abstract][Full Text] [Related]
33. Genistein selectively inhibits estrogen-induced cell proliferation and other responses to hormone stimulation in the prepubertal rat uterus.
Gaete L; Tchernitchin AN; Bustamante R; Villena J; Lemus I; Gidekel M; Cabrera G; Carrillo O
J Med Food; 2011 Dec; 14(12):1597-603. PubMed ID: 21612459
[TBL] [Abstract][Full Text] [Related]
34. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
35. Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers.
Crabtree JS; Zhang X; Peano BJ; Zhang Z; Winneker RC; Harris HA
J Steroid Biochem Mol Biol; 2006 Sep; 101(1):11-21. PubMed ID: 16920353
[TBL] [Abstract][Full Text] [Related]
36. Hormonal regulation of uterine epithelial cell proliferation. II. Effects of estradiol and progesterone administered in combination.
Kiss R; Lenglet G; Pasteels JL; Danguy A
In Vivo; 1987; 1(5):291-6. PubMed ID: 2979796
[TBL] [Abstract][Full Text] [Related]
37. Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus.
Lee AE
J Natl Cancer Inst; 1983 Dec; 71(6):1265-9. PubMed ID: 6317935
[TBL] [Abstract][Full Text] [Related]
38. Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.
Swanson SM; Whitaker LM; Stockard CR; Myers RB; Oelschlager D; Grizzle WE; Juliana MM; Grubbs CJ
Anticancer Res; 1997; 17(6D):4639-45. PubMed ID: 9494582
[TBL] [Abstract][Full Text] [Related]
39. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
[TBL] [Abstract][Full Text] [Related]
40. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
